The U.S. Meals and Drug Administration (FDA) has permitted Zepzelca (lurbinectedin) together with Tecentriq (atezolizumab) or Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) for...
As September concludes, the panorama of hematologic oncology continues to evolve, spanning the total spectrum of blood most cancers care. Latest scientific...
The U.S. Meals and Drug Administration (FDA) has accepted its Guardant360® CDx as a companion diagnostic to establish sufferers with superior breast most...
